Navigation Links
Cepheid Reports 2009 First Quarter Results
Date:4/23/2009

19 6,802 Accrued compensation (1,996) (2,730) Deferred revenue (563) (346) ----- ----- Net cash provided by (used in) operating activities 3,178 (1,654) ----- ------- Cash flows from investing activities: Capital expenditures (1,420) (4,674) Payments for technology licenses (1,500) - Cost of acquisition, net of cash acquired (148) - Proceeds from maturities of marketable securities - 2,550 Proceeds from the sale of fixed assets 8 24 Transfer to unrestricted cash 1,500 517 ----- ----- Net cash used in investing activities (1,560) (1,583) ------- ------- Cash flows from financing activities: Net proceeds from the issuance of common shares and exercise of stock options and awards 1,551 6,732 Principal payments of bank borrowing (41) - Principal payments of notes payable - (4) ----- ----- Net cash provided by financing activities 1,510 6,728 ----- ----- Effect of exchange rate change on cash 202 33 ----- ----- Net increase in cash and cash equivalents
'/>"/>
SOURCE Cepheid
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... HILLS, Calif. , May 23, 2013  Saddleback ... recently became the first hospital on the ... robotic technology. This new surgical option provides women with ... Marc Winter , M.D., ... gynecologist and surgeon and medical director of minimally invasive ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
(Date:5/23/2013)... 2013 Pusan National University Yangsan Hospital, ... and contract research company focused on research and ... today a publication reporting the induction of functional ... and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex Inc.). ... the May 15 th , 2013 issue of ...
(Date:5/23/2013)... May 23, 2013 Watlow®, an ... complete thermal systems, recently introduced its new catalog, ... of experience in designing and manufacturing industrial heaters, ... products to serve diverse customer needs. , A ... at the beginning of the book. These options ...
Breaking Biology Technology:Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Watlow Introduces Its New Industrial Heater Catalog 2
... ROCKVILLE, Md., Sept. 14 Human Genome,Sciences, Inc. (Nasdaq: ... the,Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in ... http://www.hgsi.com (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ) ... will present,an overview of the company on Tuesday, September ...
... of Only 15 Companies Recognized Nationally, SCOTTSDALE, Ariz., ... VTIV ), was recently honored by the U.S. Department,of ... Defense Employer Support,Freedom Award. The award, sponsored by the ... Reserve (ESGR), is the highest honor,bestowed upon America,s employers ...
... PTN ) announced today results for its fourth,quarter and fiscal ... of,$6.1 million, or ($0.07) per basic and diluted share, for ... of $7.9 million, or ($0.11) per basic,and diluted share, for ... June 30, 2007 were $2.6 million, compared to $5.0 million ...
Cached Biology Technology:CHS Receives Prestigious Honor from Department of Defense 2CHS Receives Prestigious Honor from Department of Defense 3Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 2Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 3Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 4Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 5Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 6Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 7Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 8
(Date:5/23/2013)... per year, carrying more than 284 million tons of cargo, ... dollars in toll fees for the Panama Canal Authority. Each ... of water are used from Gatun Lake, which is also ... in the isthmus. , However, the advent of very ... the ships at sea, has demanded change. The Panama Canal ...
(Date:5/23/2013)... prostate cancer patients unnecessarily undergo surgery or harsh ... between slow-growing and aggressive forms of the disease. ... Hopkins Medical Institutes are developing technology that allows ... for relatively mild treatments or take drastic measures. ... Madabhushi, an associate professor of biomedical engineering at ...
(Date:5/23/2013)... the team reveal the interplay of brain chemicals which ... Wellcome Trust and BBSRC. , By changing the ... perceptual abilities. While these changes can affect the strength ... fidelity of that response. , Lead author ... communicate with others, you can make yourself better heard ...
Breaking Biology News(10 mins):Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... AURORA, Colo. (Jan. 5, 2011) The ... during childbirth has plummeted 59 percent over the last ... techniques, according to a recent study. The report,s ... director of Obstetric Anesthesia at the University of Colorado ...
... the bulk of the world,s fisheries including small-scale, ... for food could be sustained using community-based co-management. ... and never will be managed by strong centralized ... them," according to Nicolas Gutirrez, a University of Washington ...
... international team of physicists and neuroscientists has reported a ... more than seven times faster than currently possible. ... journal PLoS ONE , a University of California, ... and Oxford University in the United Kingdom describe two ...
Cached Biology News:Deaths from anesthesia during childbirth plummet 2Co-management holds promise of sustainable fisheries worldwide 2Co-management holds promise of sustainable fisheries worldwide 3Major advance in MRI allows much faster brain scans 2Major advance in MRI allows much faster brain scans 3Major advance in MRI allows much faster brain scans 4Major advance in MRI allows much faster brain scans 5
... reduce the chance of error. Thats the ... using Beckman Coulters extensive experience in laboratory ... the CEQ 8000 is a fully automated ... the capillary array with a patented linear ...
... Mouse monoclonal [6331] to Salmonella typhimurium The ... Enterobacteriaceae. The genus is composed of Gram-negative bacilli ... 3 major antigens; the "H" or flagellar antigen ... antigen (part of the LPS moiety) and the ...
... H-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH 2 (Disulfide ... peptide and 1 ... I-labelled peptide, please see ... ([ 1 2 ...
This free-standing laminar flow hood provides a horizontal flow of HEPA-filtered air to create a clean processing area. Air return slots along the front and side edges of the work area enhance system...
Biology Products: